The Pharmacy Quality Alliance (PQA) is seeking comments on its “Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models.” This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
Included in the proposal are measure concepts relevant to community and specialty pharmacy. The PQA intends to develop the measures with a time-focused approach based on practical deadlines for measure availability for upcoming Medicare plan years.
The proposal was developed by the consensus achieved in a PQA workshop that included community pharmacy, specialty pharmacy, health plan, pharmacy benefit management, and association representatives. Once developed, the measures could be used in value-based models in Medicare Part D and other programs.
In a prepared statement, Laura Cranston, RPh, PQA Chief Executive Officer, emphasized the importance of this proposal.
“PQA stakeholders recognize an expanding role for community pharmacists that can be measured. Pharmacy clinical services and the measures that document them are an important direction for PQA’s measure set in the medium and long term," said Cranston.
PQA member and public comments will be accepted through September 6 at 5:00 pm ET via a form on the PQA website.
Reference
PQA seeks comments on proposed standard measure set for pharmacy accountability in value-based models [news release]. Alexandria, VA: Pharmacy Quality Alliance; August 22, 2019. https://www.pqaalliance.org/measure-set-comment-period. Accessed August 23, 2019.
Comments Sought on Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models
This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
The Pharmacy Quality Alliance (PQA) is seeking comments on its “Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models.” This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
Included in the proposal are measure concepts relevant to community and specialty pharmacy. The PQA intends to develop the measures with a time-focused approach based on practical deadlines for measure availability for upcoming Medicare plan years.
The proposal was developed by the consensus achieved in a PQA workshop that included community pharmacy, specialty pharmacy, health plan, pharmacy benefit management, and association representatives. Once developed, the measures could be used in value-based models in Medicare Part D and other programs.
In a prepared statement, Laura Cranston, RPh, PQA Chief Executive Officer, emphasized the importance of this proposal.
“PQA stakeholders recognize an expanding role for community pharmacists that can be measured. Pharmacy clinical services and the measures that document them are an important direction for PQA’s measure set in the medium and long term," said Cranston.
PQA member and public comments will be accepted through September 6 at 5:00 pm ET via a form on the PQA website.
Reference
PQA seeks comments on proposed standard measure set for pharmacy accountability in value-based models [news release]. Alexandria, VA: Pharmacy Quality Alliance; August 22, 2019. https://www.pqaalliance.org/measure-set-comment-period. Accessed August 23, 2019.
Middletown Pharmacy and Wellness Staff Care for the Community
April 18th 2024Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform
April 5th 2024Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events
April 18th 2024Pharmacy Focus: OTC Contraception and Reproductive Health
March 29th 2024Understand the Impact of the ACA on Women’s Equity and Accessible Contraceptives
April 17th 2024Pharmacist Spotlight: Christian Hartman, PharmD, MBA, FSMSO
April 17th 2024Middletown Pharmacy and Wellness Staff Care for the Community
April 18th 2024Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform
April 5th 2024Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events
April 18th 2024Pharmacy Focus: OTC Contraception and Reproductive Health
March 29th 2024Understand the Impact of the ACA on Women’s Equity and Accessible Contraceptives
April 17th 2024Pharmacist Spotlight: Christian Hartman, PharmD, MBA, FSMSO
April 17th 2024